Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers

October 13th - October 15th, 2022



- To ensure the safety of our attendees, faculty, and exhibitors in light of COVID-19, this conference will be a virtual (online) event. -

The demand for cancer care is expected to grow 40% over the next six years and ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of patients, advanced practice providers (APPs), whose education and training is focused on health promotion, disease prevention, and primary care medical management, have increasingly been sought to fill the shortage. However, many APPs have little background or training in oncology. As a result, oncology practices need to provide new staff with an onboarding program that helps to establish a working baseline level of knowledge of hematology and oncology.

To help APPs prepare for a new career in the specialty of oncology, Horizon CME in partnership with APAO has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this two-and-a-half-day program, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team.

This program is appropriate for new APPs, nurses, and pharmacists in oncology, clinicians seeking a review, or clinicians considering a career in oncology.




 Early Bird


 September 13, 2022



 October 6, 2022

 General Registration


 October 15, 2022




 Industry Employee** registration is date based pricing +$200

*Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact info@horizoncme.com for further information.

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

Learning Objectives.

  • Describe the presentation, evaluation, and treatment of common, solid, and hematologic malignancies
  • Recognize the presentation, evaluation, and treatment of common benign hematologic disorders
  • Summarize the role of genetics and molecular testing in cancer care
  • Compare and contrast the various types of cancer treatment including stem cell transplant, chemotherapy, targeted therapies, radiotherapy, and immunotherapy
  • Identify and appropriately manage common oncologic emergencies
  • Outline the role of palliative care and effectively incorporate it into oncology practice

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By


Course starts in 2 months

Base Price $125.00 Early Bird Deadline: 9/13/2022